Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bliss GVS Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:25-08-2010
25-08-2010
Joint Venture in Kuwait
Bliss GVS Pharma Ltd has informed BSE that the Company has signed a Joint Venture Agreement with Kuwait Saudi Pharmaceutical Industries Co. at Kuwait for establishing a Suppository Line Manufacturing facility in Kuwait.05-08-2010
Outcome of AGM
Bliss GVS Pharma Ltd has informed BSE that the members at the 25th Annual General Meeting (AGM) of the Company held on August 03, 2010, inter alia, have accorded to the following:1. Approved and adopted Profit and Loss Account for the year ended March 31, 2010, Balance Sheet as at that day and the Reports of Directors and Auditors thereon....03-08-2010
Outcome of Board Meeting
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 28, 2010, has approved the following:- Subject to section 314 of the Companies Act 1956, Mr. Gagan Harsh Sharma appointed as General Manger of the Company relative of Mr. S. N. Kamath - Promoter & Managing Director of the Company.30-07-2010
Financial Results for Jun 30, 2010
Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the Quarter ended June 30, 2010.28-07-2010
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bliss GVS Pharma Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:22-06-2010
Purchase of Equity Share
Bliss GVS Pharma Ltd has informed BSE that Mr. Gautam R. Ashra have purchased 23050 equity Shares of the Company at an average rate of Rs. 38.99 per share.21-06-2010
Fixes Book Closure for Dividend & AGM
Bliss GVS Pharma Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 26, 2010 to July 30, 2010 (both days inclusive) for the purpose of Payment of Dividend & 25th Annual General Meeting (AGM) of the Company to be held on August 03, 2010.10-06-2010
Board recommends Dividend
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2010, inter alia, has approved the following:1. Recommendation of 50% Dividend i.e. Rs. 0.50 per equity share for the year ended March 31, 2010.2. Fixed the date of the 25th Annual General Meeting on August 03, 2010.30-05-2010